Hamara AYUSH
The only portal for consumers in India and across the world to access information on Traditional Healthcare. We aim to empower you with credible and scientific information on the products and services that will enable you to make an informed choice. Our portal also provides scientific papers on various practices of AYUSH published by various journals and institutions in a simple and easy-to-understand language. We also share information of providers who are accredited or certified by authorized accredited bodies and mandated institutions as part of the existing laws of India and other regulatory bodies.
This ONE STOP PORTAL in the interest of the consumers is supported by all like-minded bodies that are committed to making Ayush a global brand in the interest of citizens staying healthy, seeking medical treatment and accessing quality healthcare as part of the Universal Health Coverage objectives under AYUSHMAAN BHARAT, promoted and managed by the National Health Authority, Ministry of Health & Family Welfare, Government of India.
OUR
objectives
ABOUT
AYUSH
There is an urgent need to invest at least 5% of the GDP into healthcare in our country and substantial amount should be invested in preventive care by linking all the Primary Healthcare Centres with AYUSH, especially with focus on all the 1.5 lakhs Health & Wellness Centres identified in the country under PMJAY (Ayushman Bharat). National Accreditation Board for Healthcare & Service Providers (NABH) is a Board under Quality Council of India (QCI), which has developed NABH entry level AYUSH certification standards for hospitals and AYUSH Centres, drafted in collaboration with Ministry of AYUSH. The objective is twofold, One is to bring standardization and uniformity in AYUSH healthcare delivery and Secondly to provide as empanelment criteria for coverage under health insurance. Insurance Regulatory and Development Authority of India (IRDAI) wants to ensure quality assurance of Healthcare Organizations (HCOs) on certain benchmarks defined for patient safety so that the regulator has a sizeable number of hospitals, which can cater to the cashless facility extended to AYUSH sector. NABH has partnered with IRDAI to carry out certification of such Healthcare Organizations for establishing a nationwide ecosystem. It is strongly recommended that there should be mandatory entry level quality certification of AYUSH Health and Wellness Centres. These are Government managed centres providing only OPD and day care services. Quality systems are the need of the hour. Peer review and certification by third party instills lots of confidence to community and consumers.
Infrastructure must be greatly enhanced in AYUSH Pharmacopoeia India (API) by linking with existing Laboratories accredited/certified by NABL or establish new laboratories in different Government Institutions to ensure prompt service to the citizens and manufacturers. The status of PCIM (Pharmacopoeial Commission of Indian Medicine) is raised at par with IPC (India Pharmacopeia Commission). It was agreed that Ministry of Health & Family Welfare (MoHFW) and Ministry of AYUSH (MoA) should jointly take the responsibility to regularly examine, revise and update Specifications of plant materials, finished products and packaging materials, as per already available research-facts from different laboratories, across the World. We need to build robust infrastructure of AYUSH pharmacopoeia laboratory for setting quality standards, new monograph development and continuous revision and harmonisation of raw materials monographs used in Ayurveda, Unani and Siddha products. Instead of setting separate laboratories, MoUs should be collaborated with various Universities, IITs and central laboratories, where Incubators and central instrumentation facilities are already available by Government Agencies like DST, DBT and others. Ayurvedic services need to be strengthened, on a priority basis, for clinical laboratory, imaging facilities and direct (pratyaksha) visualization/intervention by endoscopy. The Ministry of AYUSH should approve Clinical trial hospitals in central and regional levels, which would facilitate researchers & manufacturers to conduct clinical trials as per international norms.